• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Conditionability of cancer chemotherapy patients.

作者信息

Ingle R J, Burish T G, Wallston K A

出版信息

Oncol Nurs Forum. 1984 Jul-Aug;11(4):97-102.

PMID:6566342
Abstract
摘要

相似文献

1
Conditionability of cancer chemotherapy patients.癌症化疗患者的可适应性
Oncol Nurs Forum. 1984 Jul-Aug;11(4):97-102.
2
Psychological parameters of chemotherapy-induced conditioned nausea and vomiting: a review.化疗引起的条件性恶心和呕吐的心理参数：综述
Cancer Nurs. 1984 Dec;7(6):483-90.
3
Psychologic factors: their effect on nausea and vomiting experienced by clients receiving chemotherapy.
Oncol Nurs Forum. 1983 Summer;10(3):76-81.
4
Association of chemotherapy related nausea and vomiting with pretreatment anxiety.
Oncol Nurs Forum. 1986 Jan-Feb;13(1):41-7.
5
Anticipatory nausea and vomiting associated with cancer chemotherapy.
Oncol Nurs Forum. 1986 Jan-Feb;13(1):35-40.
6
The effects of music therapy and guided visual imagery on chemotherapy induced nausea and vomiting.音乐疗法和引导式视觉意象对化疗引起的恶心和呕吐的影响。
Oncol Nurs Forum. 1985 Sep-Oct;12(5):47-52.
7
A pilot study of a relaxation technique for management of nausea and vomiting in patients receiving cancer chemotherapy.一项关于放松技巧对癌症化疗患者恶心呕吐管理作用的初步研究。
Cancer Nurs. 2007 Mar-Apr;30(2):163-7. doi: 10.1097/01.NCC.0000265007.87311.d0.
8
[Anticipatory nausea and anticipatory vomiting, food aversion and anticipatory immunomodulation: classical conditioning in cytostatic drug treatment of pediatric chemotherapy patients].[预期性恶心与预期性呕吐、食物厌恶及预期性免疫调节：小儿化疗患者细胞毒性药物治疗中的经典条件作用]
Praxis (Bern 1994). 1998 Sep 2;87(36):1140-7.
9
The pathophysiology of treatment-related nausea and vomiting in cancer patients: current models.癌症患者治疗相关恶心和呕吐的病理生理学：当前模型
Indian J Physiol Pharmacol. 2004 Jul;48(3):256-68.
10
[Nausea and vomiting before the administration of cytostatic agents].[细胞毒性药物给药前的恶心和呕吐]
Ned Tijdschr Geneeskd. 1986 Aug 16;130(33):1479-81.

引用本文的文献

1
Efficacy of Olanzapine-Triple Antiemetic Regimen in Patients with Gastrointestinal Tumor and High Risk of Chemotherapy-Induced Nausea and Vomiting Receiving Moderately Emetogenic Chemotherapy: A Retrospective Study.奥氮平三联止吐方案在接受中度致吐性化疗且有高化疗致恶心和呕吐风险的胃肠道肿瘤患者中的疗效：一项回顾性研究
Cancer Manag Res. 2020 Jul 29;12:6575-6583. doi: 10.2147/CMAR.S254398. eCollection 2020.
2
The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.奥氮平联合昂丹司琼和地塞米松预防高致吐性化疗引起的恶心和呕吐的疗效和安全性：一项随机、双盲、安慰剂对照临床试验。
Int J Clin Oncol. 2020 Feb;25(2):396-402. doi: 10.1007/s10147-019-01570-3. Epub 2019 Nov 27.
3
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy: Results of the Korean South West Oncology Group (KSWOG) Study.一项奥氮平预防中度致吐性化疗所致恶心呕吐的随机、双盲、安慰剂对照研究：韩国西南肿瘤协作组（KSWOG）研究的安全性和疗效结果。
Cancer Res Treat. 2019 Jan;51(1):90-97. doi: 10.4143/crt.2017.577. Epub 2018 Feb 27.
4
The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India.奥氮平与阿瑞匹坦在高致吐性化疗中的疗效、安全性及成本效益：一项来自印度南部的初步研究
Chemother Res Pract. 2016;2016:3439707. doi: 10.1155/2016/3439707. Epub 2016 Jan 27.
5
Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients.癌症患者化疗所致恶心呕吐的当前药物治疗。
Expert Opin Pharmacother. 2013 Apr;14(6):757-66. doi: 10.1517/14656566.2013.776541.
6
Chemotherapy-induced nausea and vomiting: pathophysiology and therapeutic principles.化疗所致恶心和呕吐：病理生理学和治疗原则。
Clin Transl Oncol. 2012 Jun;14(6):413-22. doi: 10.1007/s12094-012-0818-y.